Manzamine B and E and Ircinal A Related Alkaloids from an Indonesian <i>Acanthostrongylophora</i> Sponge and Their Activity against Infectious, Tropical Parasitic, and Alzheimer's Diseases
Karumanchi V. Rao(Emory University), Mark T. Hamann(James Cook University), Jiangnan Peng(Sinochem Group (China)), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Kristine L. Willett(University of Mississippi), Subagus Wahyuono(Universitas Gadjah Mada), Miguel Medina(Baptist Hospital of Miami), Shabana I. Khan(University of Mississippi), Scott G. Franzblau(University of Illinois Chicago), Marwa S. Donia(Universitas Gadjah Mada), Esther García‐Palomero(Universitat de Barcelona), D. A. Alonso(Neuron BioPharma (Spain)), Babu L. Tekwani(University of Mississippi)
Cited by 138
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
|American Journal Of Pathology|2002|331